Stem Cell Medical Interpreting
We provide Korean↔Japanese interpreting at regenerative-medicine explanations and meetings in Japan. All medical judgements are made by the medical team.
Read more - Stem Cell Medical Interpreting
Stem Cell Medical Interpreting
Japanese bone marrow stem cell researchpresented on the basis of papers and authoritative sources.
We introduce bone marrow stem cell research published by Japanese universities and research institutes, together with the original paper sources, and provide Korean–Japanese medical interpreting so that explanations given by medical teams in Japan can be understood accurately.
FTH is not a medical institution. It does not diagnose, treat or make medical judgements; its purpose is to provide information and on-site interpreting.
AI-generated image · not real people or institutions
Medical Document & Paper Translation
We translate medical records, test results, consent documents and stem cell research papers between Korean, Japanese and English.
Read more - Medical Document & Paper TranslationStem Cell Research Results
We summarise research results from Japanese universities and institutes by condition — spinal cord injury, Parkinson's disease, stroke, cirrhosis and more — with paper sources.
Read more - Stem Cell Research ResultsStem Cell Research
Stem cell research results by condition
Which research results have been reported for which conditions, organised by field with Japanese universities and institutes and international papers as sources.
Autism, Developmental Disorders & Cerebral Palsy
Design and results of stem cell clinical studies in autism spectrum disorder, developmental disorders, cerebral palsy and intellectual disability.
Read moreBrain Disorders (Stroke, Parkinson's, Dementia, ALS, MS)
Stem cell research in stroke, Parkinson's disease, dementia, ALS, multiple sclerosis and epilepsy.
Read moreSpinal Cord Injury & Knee Joints
Japan's conditional approval of a regenerative product for spinal cord injury, and stem cell research in the knee.
Read moreHeart, Liver & Diabetes
Size and results of stem cell clinical studies reported in heart failure, myocardial infarction, liver cirrhosis and diabetes.
Read moreWomen's Health & Ageing
Randomised trials in older adults with frailty, and the state of research in women's health.
Read moreRegulation & Other (Crohn's, Pain, etc.)
Risk classes and procedures under Japan's regenerative medicine act, and research in Crohn's disease, chronic pain, depression and cancer treatment side effects.
Read more
Why Japan
Japanese stem cell research, as published
Japan is where iPS cells were first reported and a country that has approved stem cell regenerative medical products. FTH conveys research results published by Japanese universities and institutes in Korean, exactly as stated in papers and public-agency materials.
- 01
Results from Japanese institutions
We present research from Sapporo Medical University (spinal cord injury, stroke), Kyoto University (iPS cells for Parkinson's disease), Yamaguchi University (cirrhosis) and others, with paper sources.
- 02
Approved products and regulation
We summarise products approved for acute GVHD (2015) and spinal cord injury (2018), and Japan's regenerative medicine system.
- 03
Always sourced
Every item cites papers or public-agency materials, and nothing is added that is not in the original.
- 04
Neutral information
We do not introduce or recommend any medical institution; the suitability of treatment is decided by the medical team.
0Stem cell information fields
0Working languages (KO·JA·EN)
0+Papers & public sources cited
0%Commitment to citing sources
Research Notes
Research notes by field
Regulation & Other
Stem Cell Secretome for Chronic Pain — Exosome Injection for Disc Pain in 76 People and a Joint Pain Pilot (2026)
Read more
Women & Ageing
Exosomes for Ovarian Aging — Egg Maturation and Fat-Derived Stem Cell Results in Diminished Ovarian Reserve (2026)
Read more
Heart, Liver & Metabolism
Liver Cirrhosis Stem Cells: Cord MSC Phase 1 via the Hepatic Artery and 4-Year Macrophage Therapy Results
Read more
Spine & Joints
Knee Meniscus Stem Cells: Japan Approves SAVYSCUS, the First Regenerative Product for Meniscus Injury
Read more
Brain & Nerves
Bone Marrow Stem Cells for Brain Injury: AKUUGO Launches in Japan with Insurance Coverage, and New TBI Clinical Results
Read more
Neurodevelopment
Stem Cells for Autism: 2026 Clinical Results — Intrathecal Umbilical Cord MSC Phase I and a Randomized Cord Blood Trial
Read more
Our Principles
Three principles FTH keeps
Latest Blog
View all articlesLatest stem cell information
Stem Cell Secretome for Chronic Pain — Exosome Injection for Disc Pain in 76 People and a Joint Pain Pilot (2026)
After a single injection of stem cell exosomes, 90.9% of 76 people with neck or low back disc pain reported meaningful relief at 2 weeks, and 73.2% at 2 years. In a 10-person study of Ehlers-Danlos syndrome with persistent joint pain, 6 improved across several symptoms after bone marrow stem cell secretome.
Read moreExosomes for Ovarian Aging — Egg Maturation and Fat-Derived Stem Cell Results in Diminished Ovarian Reserve (2026)
In a randomized trial of 32 women with diminished ovarian reserve, immature eggs cultured with autologous exosomes matured at 63.63% versus 11.53% in standard culture. In a study of 29 women given fat-derived stem cells into the ovaries, AMH rose, and a larger rise was linked to a higher chance of obtaining eggs.
Read moreLiver Cirrhosis Stem Cells: Cord MSC Phase 1 via the Hepatic Artery and 4-Year Macrophage Therapy Results
In a phase 1 trial, umbilical cord-derived mesenchymal stem cells infused into the hepatic artery were followed by higher albumin and better quality of life. Edinburgh's macrophage therapy was reported to raise four-year transplant-free survival to 70%.
Read moreContact
Information Inquiry
Call us02-517-5117Email us1004@109.co.krFTH Co., Ltd.
313 Central-ro, Yeonsu-gu, Incheon 22006, Republic of Korea (Songdo-dong, Songdo C-Walk In Terrace Halla)
FTH is not a medical institution but a company providing stem cell research information and translation and interpreting services. We share general research information based on published academic sources; we do not diagnose, treat or make medical judgements, and our purpose is to provide information and on-site interpreting.